Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.59 |
| ▸ | ACACB | O00763 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.47 |
| ▸ | WDR91 | A4D1P6 | 2/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | CDC7 | O00311 | 1/20 | 0.45 |
| ▸ | PLK4 | O00444 | 1/20 | 0.45 |
| ▸ | AURKA | O14965 | 1/20 | 0.45 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.45 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.45 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.45 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.45 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.45 |
| ▸ | PAK4 | O96013 | 1/20 | 0.45 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11759154 | 0.95 | L3MBTL1 (0.73) | L3MBTL1HRH3ACACBCYP1A2CYP2C9 | |
| SCHEMBL11200681 | 0.91 | L3MBTL1 (0.76) | L3MBTL1HRH3ACACBCYP1A2CYP2C9 | |
| SCHEMBL13853398 | 0.86 | L3MBTL1 (0.65) | L3MBTL1HRH3ACACBCYP1A2CYP2C9 | |
| SCHEMBL10399987 | 0.84 | L3MBTL1 (0.67) | L3MBTL1HRH3ACACBCYP1A2CYP2C9 | |
| SCHEMBL19717008 | 0.84 | L3MBTL1 (0.67) | L3MBTL1HRH3ACACBCYP1A2CYP2C9 | |
| SCHEMBL2774412 | 0.83 | L3MBTL1 (0.66) | L3MBTL1HRH3ACACBWDR91KMT2A | |
| SCHEMBL256037 | 0.82 | L3MBTL1 (0.65) | L3MBTL1HRH3ACACBCYP1A2CYP2C9 | |
| SCHEMBL6824717 | 0.82 | L3MBTL1 (0.65) | L3MBTL1HRH3ACACBCYP1A2CYP2C9 | |
| SCHEMBL5578262 | 0.82 | L3MBTL1 (0.65) | L3MBTL1HRH3ACACBCYP1A2CYP2C9 | |
| SCHEMBL632892 | 0.82 | L3MBTL1 (0.65) | L3MBTL1HRH3ACACBCYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5124444-A | LACTAM-CONTAINING COMPOSITIONS AND METHODS USEFUL FOR THE EXTRACTION OF NUCLEIC ACIDS | MICROPROBE CORPORATION (US) | 1992-06-23 | — | — | US | claimed |
| US-5106730-A | Lactam-containing compositions and methods useful for the hybridization of nucleic acids | MICROPROBE CORPORATION (US) | 1992-04-21 | — | — | US | claimed |
| WO-1991002088-A1 | LACTAM-CONTAINING COMPOSITIONS AND METHODS USEFUL FOR THE HYBRIDIZATION OF NUCLEIC ACIDS | MICROPROBE CORPORATION (US) | 1991-02-21 | — | — | WO | claimed |
| WO-1991002089-A1 | LACTAM-CONTAINING COMPOSITIONS AND METHODS USEFUL FOR THE EXTRACTION OF NUCLEIC ACIDS | MICROPROBE CORPORATION (US) | 1991-02-21 | — | — | WO | claimed |
| EP-0005143-A1 | 1-Benzoyl-2-pyrrolidinone derivative, processes for its preparation and medicaments containing it | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-11-14 | — | — | EP | claimed |
| US-20090137577-A1 | HETEROCYCLIC COMPOUNDS | PFIZER INC. | 2009-05-28 | — | — | US | disclosed |
| US-5376529-A | Lactam-containing compositions and methods useful for the hybridization of nucleic acids | MICROPROBE CORPORATION (US) | 1994-12-27 | — | — | US | disclosed |
| US-5376529-A | Lactam-containing compositions and methods useful for the hybridization of nucleic acids | MICROPROBE CORPORATION (US) | 1994-12-27 | — | — | US | disclosed |
| US-5124444-A | LACTAM-CONTAINING COMPOSITIONS AND METHODS USEFUL FOR THE EXTRACTION OF NUCLEIC ACIDS | MICROPROBE CORPORATION (US) | 1992-06-23 | — | — | US | disclosed |
| US-5124444-A | LACTAM-CONTAINING COMPOSITIONS AND METHODS USEFUL FOR THE EXTRACTION OF NUCLEIC ACIDS | MICROPROBE CORPORATION (US) | 1992-06-23 | — | — | US | disclosed |
| US-5106730-A | Lactam-containing compositions and methods useful for the hybridization of nucleic acids | MICROPROBE CORPORATION (US) | 1992-04-21 | — | — | US | disclosed |
| US-5106730-A | Lactam-containing compositions and methods useful for the hybridization of nucleic acids | MICROPROBE CORPORATION (US) | 1992-04-21 | — | — | US | disclosed |
| WO-1991002088-A1 | LACTAM-CONTAINING COMPOSITIONS AND METHODS USEFUL FOR THE HYBRIDIZATION OF NUCLEIC ACIDS | MICROPROBE CORPORATION (US) | 1991-02-21 | — | — | WO | disclosed |
| WO-1991002089-A1 | LACTAM-CONTAINING COMPOSITIONS AND METHODS USEFUL FOR THE EXTRACTION OF NUCLEIC ACIDS | MICROPROBE CORPORATION (US) | 1991-02-21 | — | — | WO | disclosed |
| WO-1991002089-A1 | LACTAM-CONTAINING COMPOSITIONS AND METHODS USEFUL FOR THE EXTRACTION OF NUCLEIC ACIDS | MICROPROBE CORPORATION (US) | 1991-02-21 | — | — | WO | disclosed |
| WO-1991002088-A1 | LACTAM-CONTAINING COMPOSITIONS AND METHODS USEFUL FOR THE HYBRIDIZATION OF NUCLEIC ACIDS | MICROPROBE CORPORATION (US) | 1991-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137577-A1 | HETEROCYCLIC COMPOUNDS | CYP2D6, ABCG2, CYP2B6 | L3MBTL1 4751/4885HRH3 1409/4885ACACB 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.